Legend Biotech: Barclays cuts target price to $68 from $74
LEGN•Barclays cut its target price for Legend Biotech to $68 from $74.
Related News
Daqo New Energy schedules Q3 unaudited results release, earnings call
DQ•
Fair Isaac Corporation: Raymond James cuts target price to $1230 from $1750
FICO•
Molson Coors Beverage Company: TD Cowen cuts target price to $37 from $43
TAP•
Alaunos Therapeutics completes acquisition of Velaris Therapeutics
TCRT•
Enodia Therapeutics announces research collaboration and license agreement with Pfizer to develop SEC61-targeting small molecules
PFE•